"50228-332-30" National Drug Code (NDC)

NDC Code	50228-332-30
Package Description	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-332-30)
Product NDC	50228-332
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Nevirapine
Non-Proprietary Name	Nevirapine
Dosage Form	TABLET, EXTENDED RELEASE
Usage	ORAL
Start Marketing Date	20170808
Marketing Category Name	ANDA
Application Number	ANDA207467
Manufacturer	ScieGen Pharmaceuticals Inc
Substance Name	NEVIRAPINE
Strength	100
Strength Unit	mg/1
Pharmacy Classes	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]